NCT00490074View on ClinicalTrials.gov

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

147

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

October 31, 2009

Conditions

HIV Infections

Interventions

BIOLOGICAL

DNA-C

1.0mg per ml of DNA HIV-C vaccine 2x2 ml IM

BIOLOGICAL

NYVAC-C

NYVAC-C 1 ml IM

Trial Locations (2)

1011

Centre Hospitalier Universitaire Vaudois CHUV, Lausanne

94010

Hôpital Henri Mondor, Créteil

All Listed Sponsors

collaborator

EuroVacc Foundation

OTHER

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00490074 - Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers | Biotech Hunter | Biotech Hunter